{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "Y1699C and G2019S mutants"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "R1441C mutant"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005128"
  },
  "Experiment Method": [
    {
      "Assay Method": "Oxidative stress viability assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293, SH-SY5Y",
        "Description": "HEK293 and SH-SY5Y cells were exposed to H2O2-induced oxidative stress."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "Y1699C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced cell viability",
          "Result Description": "Wild-type LRRK2 enhanced cell viability under oxidative stress, while Y1699C mutants did not."
        },
        {
          "Variant": "G2019S",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced cell viability",
          "Result Description": "Wild-type LRRK2 enhanced cell viability under oxidative stress, while G2019S mutants did not."
        },
        {
          "Variant": "R1441C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced cell viability",
          "Result Description": "R1441C mutant showed reduced tolerance to oxidative stress compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control for enhanced viability."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Mutant variants (Y1699C, G2019S, R1441C) served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability above 80% under oxidative stress",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability below 60% under oxidative stress",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "ERK pathway activation assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293, SH-SY5Y",
        "Description": "Cells were analyzed for ERK pathway activation in response to LRRK2 expression."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "Y1699C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced ERK activation",
          "Result Description": "Wild-type LRRK2 induced ERK activation, while Y1699C mutants showed impaired signaling."
        },
        {
          "Variant": "G2019S",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced ERK activation",
          "Result Description": "Wild-type LRRK2 induced ERK activation, while G2019S mutants showed impaired signaling."
        },
        {
          "Variant": "R1441C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced ERK activation",
          "Result Description": "R1441C mutant showed reduced ERK activation compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control for ERK activation."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Mutant variants (Y1699C, G2019S, R1441C) served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "ERK phosphorylation above 80% of baseline",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "ERK phosphorylation below 50% of baseline",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}